DrugDashboards

Daptomycin

Daptomycin · DAPTOMYCIN 500 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous · MAIA Pharmaceuticals, Inc.

NDC 70511-0182-84 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

25 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for daptomycin (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $790.29 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA217630
TE code
—
Approval date
Nov 21, 2024
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Daptomycin, Injection, 500 mg/10 mL (NDC 0143-9378-01)Jun 30, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Daptomycin (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Fresenius Kabi USA, LLCDAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.DAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.DAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.DAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 3, 2026
Mylan Institutional LLCDAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 3, 2026
Sagent PharmaceuticalsDAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 3, 2026
Xellia Pharmaceuticals USA LLCDAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 3, 2026
Xellia Pharmaceuticals USA LLCDAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 3, 2026
Accord Healthcare Inc.DAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.DAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 2, 2026
Apotex Corp.DAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.DAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.DAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
Biocon Pharma Inc.DAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
BluePoint LaboratoriesDAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.DAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.DAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 2, 2026
Civica, Inc.DAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.,DAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 2, 2026
Dr.Reddy's Laboratories Inc.,DAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCDAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
Hospira, Inc.DAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
Hospira, Inc.DAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 2, 2026
MAIA Pharmaceuticals, Inc.DAPTOMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCDAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCDAPTOMYCIN 350 mg/7mLJul 15, 2026Sep 2, 2026
Par Health USA, LLCDAPTOMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
Patheon Italia S.p.ADAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
Patheon Italia S.p.A.DAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
Qilu Pharmaceutical Co., Ltd.DAPTOMYCIN 500 mg/10mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsDAPTOMYCIN 50 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.DAPTOMYCIN 500 mg/10mLJul 15, 2026Aug 31, 2026
Aspiro Pharma LimitedDAPTOMYCIN 500 mg/10mLAug 28, 2026Aug 28, 2026
Civica, Inc.DAPTOMYCIN 500 mg/10mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Daptomycin — NDC 70511-0182-84," retrieved September 3, 2026, https://drugdashboards.com/drug/70511018284.

Free to cite with attribution — see how the data is put together.